Oncologie nieuws
- Liquid Biopsy for Colorectal Cancer Screening: Not So Bloody Fast
- EMA Recommends Extension of Therapeutic Indications for Enzalutamide
- Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
- AstraZeneca's Truqap plus Faslodex receives Japanese approval for patients with advanced HR─positive breast cancer
- Researchers discover a mechanism that could improve platinum-based cancer therapy
- Pembrolizumab Combined with Chemoradiotherapy Improves PFS in Women with Newly Diagnosed, Previously Untreated, High-Risk, Locally Advanced Cervical Cancer
- Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression
- International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
- Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810
- Failing Forward in Peripheral T-Cell Lymphoma
- Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review
- Significant iDFS Benefit with Adding Ribociclib to a Nonsteroidal Aromatase Inhibitor in the Adjuvant Treatment for HR-positive, HER2-negative EBC
- Separating distant recurrences from second primaries in head and neck squamous cell carcinomas – A DAHANCA group analysis on paired tumor samples
- Are oral cancers effectively palliated with radiotherapy? Outcomes of treatment with a modified QUAD SHOT regimen
- Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening